Tag: Gca

Explore our medication guides and pharmacology articles within this category.

Does ACTEMRA treat giant cell arteritis? Understanding its role in modern therapy

Oct 10, 2025 •

5 min read

In 2017, ACTEMRA became the first FDA-approved treatment specifically for giant cell arteritis (GCA), marking a significant advancement in managing this condition. This biologic medication offers a crucial steroid-sparing option for adults living with GCA by targeting a key inflammatory pathway.

How Fast Does ACTEMRA Work for GCA? Understanding the Timeline

Oct 10, 2025 •

2 min read

While traditional high-dose steroids typically offer symptom relief within days, ACTEMRA (tocilizumab) for GCA provides sustained, long-term remission and allows for a significant reduction in steroid use over time, with clinical improvement often observed within the first 1 to 3 months.